Business
SUO-CTC and CG Oncology Announce the Second Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award
Two applicants will each receive a Grant of $50,000 to support the development of outstanding clinical cancer research to improve the treatment of
About this update from Cg Oncology, Inc.
[{"type":"text","content":"Two applicants will each receive a Grant of $50,000 to support the development of outstanding clinical cancer research to improve the treatment of NMIBCApplications for the fellowship are due on February 27, 2026 SCHAUMBURG, Ill. and IRVINE, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) -- The Society of Urologic Oncology Clinical Trials Consortium (SUO-CTC), a national alliance of leading academic and community based uro-oncologists, and CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients with bladder cancer, today announced the second annual CG-SUO-CTC NMIBC Research Fellowship designed to support the development of outstanding clinical cancer research investigators who have demonstrated a commitment to improving the understanding and treatment of Non-Muscle Invasive Bladder Cancer (NMIBC). “There remains a significant unmet need for treating NMIBC, and this fellowship is helping advance research and drive innovation, leading to improvements in patient care. We are fortunate to have a very bright and motivated next generation of urologists entering the field, and this program offers an exceptional opportunity for them to collaborate with mentors and present their work at a prominent forum like AUA as we enter its second year,” said Colin P. N. Dinney, MD, a Professor of Urology at the University of Rochester Medical Center. “Partnering with the SUO-CTC on this fellowship reflects our shared dedication to advancing care for patients with urologic cancers,” said Ambaw Bellete, President & Chief Operating Officer, CG Oncology. “By fostering research and collaboration, this program moves us closer to innovations that can truly improve patients’ lives.” To apply for this fellowship, investigators may be working in basic, translational and clinical research fields, and they must be working in a research environment capable of supporting transformational NMIBC research. All applications are due by Friday, February 27, 2026, at 5:00 PM U.S. Eastern Time. Applications will be evaluated on the quality of the applicant’s proposed research plan and the resources and environment available to the applicant. Two applicants will each receive a Grant of $50,000. The completed project will be presented at the SUO meetin...